Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.

  title={Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.},
  author={Jennifer Briley Christian and Bhakti V Arondekar and Erin K. Buysman and Terry A Jacobson and Rose G Snipes and Ralph I Horwitz},
  journal={The American journal of medicine},
  volume={127 1},
BACKGROUND Patients with severe hypertriglyceridemia have an increased risk of cardiovascular disease and pancreatitis. Target triglyceride levels associated with clinical benefit for patients with severe hypertriglyceridemia are not currently known. This study evaluates the association between lower follow-up triglyceride levels and incidence of clinical events for patients with severe hypertriglyceridemia. METHODS By using claims data from 2 large US healthcare databases, we conducted a… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS